welcomes you to the new, improved website!
Georgios D. Tsormpas, M.D.
BACKGROUND
2019 – 2021 Royal Infirmary of Edinburgh, Specialist Cardiac Surgeon
2016 – 2019 Euromedica Geniki Kliniki Private Hospital
2015 – 2016 Euromedica – KYANOUS STAVROS
2014 – 2015 Leeds General Infirmary, Cardiac Surgeon
2010 – 2014 Euromedica – KYANOUS STAVROS
2010 Master of Valve (Mitral) course, Monaco, Prof. Gilles Dreyfus
2003 – 2009 Euromedica GENIKI KLINIKI Thessaloniki
OTHER INTERESTS
Off – Pump CABG Surgery
RALTS AVR
Minimally Invasive Cardiac Surgery (MICS)
Transcatheter Valve Therapies
Robotic Cardiac Surgery
RESEARCH
2002 – 2003 Aventis Expedition Study, a double blinded, placebo controlled multinational trial to investigate the effect of IV treatment with the Na+/H+ exhange inhibitor CARIPORIDE (HOE642) on all-cause mortality and non-fatal myocardial infarction in patients at risk for myocardial necrosis during and after coronary artery bypass graft (CABG) surgery (HOE642A/3002). Aventis Pharmaceuticals, Inc. [Cardiac Thoracic Surgery Clinic, “Georgios Papanikolaou” Hospital of Thessaloniki, Greece, Center Sub Investigator]
EDUCATION & TRAINING
2016 Minimally Invasive Mitral Repair , Munich Cardiothoracic Center, Germany
2010- Master of Valve (Mitral) course, Monaco, Prof. Gilles Dreyfus.
1999-2003 Cardiothoracic Residency, G. Papanikolaou Hosp.
1996-1999 General Surgery Residency, AHEPA Gen. University Hosp.
1986-1992 Medical School, Aristotelian University of Thessaloniki, Greece.